NGL Fine Chem's Q4 FY 2025-26 Quarterly Results

Result Summary

• NGL Fine Chem Ltd reported a 14.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 61.4%.
• Its expenses for the quarter were up by 20.1% QoQ and 44.0% YoY.
• The net profit decreased 14.0% QoQ and increased 2398.1% YoY.
• The earnings per share (EPS) of NGL Fine Chem Ltd stood at 21.83 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

## Company Overview
NGL Fine Chem Ltd is a company involved in the production and sale of pharmaceutical intermediates and bulk drugs. The company operates within the chemical and pharmaceutical industry, providing a range of products that cater to the needs of drug manufacturers and other stakeholders in the healthcare sector. Unfortunately, specific recent developments concerning the company are not available from the provided data. However, NGL Fine Chem Ltd continues to focus on its core operations in the pharmaceutical manufacturing domain.

## Revenue
In the fourth quarter of fiscal year 2026 (Q4FY26), NGL Fine Chem Ltd reported a total income of ₹151.69 crores. This represents a 14.8% increase compared to the previous quarter (Q3FY26), where the total income was ₹132.12 crores. Year-over-year, the company's total income increased significantly by 61.4% from ₹94.01 crores in Q4FY25. The substantial growth in total income over the year highlights an increase in the company's revenue-generating activities.

## Profitability
The profitability of NGL Fine Chem Ltd showed varied performance over the reported periods. In Q4FY26, the profit before tax was ₹17.81 crores, reflecting a decrease of 13.8% from ₹20.67 crores in Q3FY26. Despite this quarter-on-quarter decline, the year-over-year growth was remarkable, with a 1580.2% increase from ₹1.06 crores in Q4FY25. The profit after tax in Q4FY26 was ₹13.49 crores, down 14.0% from ₹15.69 crores in Q3FY26, but up significantly by 2398.1% from ₹0.54 crores in Q4FY25. Earnings per share followed a similar pattern, recorded at ₹21.83 in Q4FY26, down from ₹25.40 in the previous quarter, yet a significant increase from ₹0.88 in Q4FY25, marking a year-over-year growth of 2380.7%.

## Operating Metrics
The total expenses for NGL Fine Chem Ltd in Q4FY26 were ₹133.88 crores, which represents a 20.1% increase from ₹111.45 crores in Q3FY26. On a year-over-year basis, the total expenses grew by 44.0% from ₹92.94 crores in Q4FY25. The tax expense for Q4FY26 was ₹4.33 crores, a decrease of 13.1% from ₹4.98 crores in Q3FY26, but showed a substantial increase of 732.7% compared to ₹0.52 crores in Q4FY25. This variation in tax expenses is consistent with the changes in profitability metrics over the periods. The financial data indicates notable quarterly and annual changes in key operating metrics, reflecting the dynamic operational environment of NGL Fine Chem Ltd.